U S PHYSICAL THERAPY INC /NV Segments Disclosure
| For the Year Ended |
||||||||||||
|
December 31, 2025
|
December 31, 2024
|
December 31, 2023
|
||||||||||
|
(In thousands)
|
||||||||||||
|
Net revenue:
|
||||||||||||
|
Physical therapy operations
|
$
|
666,589
|
$
|
574,433
|
$
|
526,548
|
||||||
|
Industrial injury prevention services
|
114,401
|
96,912
|
78,254
|
|||||||||
|
Total Company
|
$
|
780,990
|
$
|
671,345
|
$
|
604,802
|
||||||
| Operating Costs: | ||||||||||||
|
Salaries and related costs:
|
||||||||||||
|
Physical therapy operations
|
$ | 388,641 | $ | 337,466 | $ | 302,765 | ||||||
|
Industrial injury prevention services
|
73,249 | 61,928 | 50,625 | |||||||||
|
Total salaries and related costs
|
$ | 461,890 | $ | 399,394 | $ | 353,390 | ||||||
|
Rent supplies, contract labor
and other:
|
||||||||||||
|
Physical therapy operations
|
$ | 124,226 | $ | 105,019 | $ | 97,873 | ||||||
|
Industrial injury prevention services
|
16,205 | 13,891 | 10,723 | |||||||||
|
Total rent, supplies, contract labor and other
|
$ | 140,431 | $ | 118,910 | $ | 108,596 | ||||||
|
Depreciation and amortization:
|
||||||||||||
|
Physical therapy operations
|
$ | 17,834 | $ | 14,775 | $ | 12,576 | ||||||
|
Industrial injury prevention services
|
3,225 | 3,078 | 2,384 | |||||||||
|
Total depreciation and amortization
|
$ | 21,059 | $ | 17,853 | $ | 14,960 | ||||||
|
Provision for credit losses:
|
||||||||||||
|
Physical therapy operations
|
$ | 7,562 | $ | 6,904 | $ | 6,129 | ||||||
|
Industrial injury prevention services
|
85 | 8 | 43 | |||||||||
|
Total provision for credit losses
|
$ | 7,647 | $ | 6,912 | $ | 6,172 | ||||||
|
Clinic closure costs:
|
||||||||||||
|
Physical therapy operations
|
$ | 270 | $ | 4,355 | $ | 175 | ||||||
|
Industrial injury prevention services
|
- | - | - | |||||||||
|
Total clinic closure costs
|
$ | 270 | $ | 4,355 | $ | 175 | ||||||
| Total Company | $ | 631,297 | $ | 547,424 | $ | 483,293 | ||||||
|
Gross profit:
|
||||||||||||
|
Physical therapy operations
|
$
|
128,056
|
$
|
105,914
|
$
|
107,030
|
||||||
|
Industrial injury prevention services
|
21,637
|
18,007
|
14,479
|
|||||||||
|
Total Company
|
$
|
149,693
|
$
|
123,921
|
$
|
121,509
|
||||||
|
|
||||||||||||
|
Impairment of goodwill and other intangible assets
|
||||||||||||
|
Industrial injury prevention services
|
$ | - | $ | - | $ | 17,495 | ||||||
|
Total impairment of goodwill and other intangible assets
|
$ | - | $ | - | $ | 17,495 | ||||||
| Impairment of assets held for sale | ||||||||||||
|
Physical therapy operations
|
$ | - | $ | 2,418 | $ | - | ||||||
|
Total impairment of assets held for sale
|
$ | - | $ | 2,418 | $ | - | ||||||
|
Unallocated amounts
|
||||||||||||
|
Corporate office costs
|
$ | 69,260 | $ | 58,290 | $ | 51,953 | ||||||
|
Interest expense, debt and other
|
9,459 | 8,015 | 9,303 | |||||||||
|
Interest income from investments
|
(105 | ) | (3,941 | ) | (3,774 | ) | ||||||
|
Change in fair value of contingent earn-out consideration
|
(6,244 | ) | 219 | 1,550 | ||||||||
|
Change in revaluation of put-right liability
|
1,322 | 82 | (2,582 | ) | ||||||||
|
Equity in earnings of unconsolidated affiliate
|
(1,477 | ) | (1,014 | ) | (955 | ) | ||||||
|
Loss on sale of partnership
|
123 | - | - | |||||||||
|
Relief Funds
|
- | - | (467 | ) | ||||||||
|
Other
|
(458 | ) | (357 | ) | (390 | ) | ||||||
|
Total unallocated amounts
|
71,880 | 61,294 | 54,638 | |||||||||
|
Income before taxes
|
$ | 77,813 | $ | 60,209 | $ | 49,376 | ||||||
| December 31, 2025 | December 31, 2024 | |||||||
| Assets: | ||||||||
|
Goodwill:
|
||||||||
|
Physical therapy operations
|
$ | 604,440 | $ | 579,046 | ||||
|
Industrial injury prevention services
|
87,952 | 88,106 | ||||||
|
Total goodwil
|
$ | 692,392 | $ | 667,152 | ||||
|
All other assets:
|
||||||||
|
Physical therapy operations
|
434,804
|
$
|
415,039
|
|||||
|
Industrial injury prevention services
|
76,814
|
85,276
|
||||||
|
Total all other assets
|
511,618 | 500,315 | ||||||
|
Total Assets
|
$
|
1,204,010
|
$
|
1,167,467
|
||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 1, 2021 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.